Loading clinical trials...
Loading clinical trials...
A Study of Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Conditions
Interventions
Ibrutinib
ECG
+14 more
Locations
2
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Washington University, School of Medicine
St Louis, Missouri, United States
Start Date
May 10, 2021
Primary Completion Date
June 24, 2024
Completion Date
October 1, 2024
Last Updated
January 23, 2026
NCT02611180
NCT05502783
NCT05509582
NCT04146207
NCT02519816
NCT01106833
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions